Wockhardt recalls two drugs; Dalton to make Andes product; French CMO gets cash infusion for expansion;

> India's Wockhardt is recalling small amounts of a couple of drugs because the FDA cited it for not thoroughly investigating customer complaints and getting to the root of the issues. Here and here

> According to a report from CPhI Turkey, manufacturers report that exports to traditional markets were down but exports to South Korea and Russia were up. Release

> Dalton Pharma Services has an agreement to provide Andes Biotechnologies large molecule sterile dose manufacturing services for its Phase I/II clinical trials. Release

> French CMO Indicia Production has received an undisclosed investment from the Amundi Private Equity Funds which it will use for expansion. Release

> Drug manufacturers and suppliers attending CPhI Russia reported that they see the Russian market as a gateway to CIS countries. Release

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.